Gene Therapy Shows Promise for Age-Related Macular Degeneration
(MedPage Today) -- NEW YORK CITY -- A gene therapy for age-related macular degeneration (AMD) led to extended treatment-free intervals and durable improvement in visual acuity and retinal thickening, a preliminary trial showed.
ADVM-022 (ixoberogene...
Source: MedPage Today Primary Care - Category: Primary Care Source Type: news
More News: Age-Related Macular Degeneration (AMD) | Gene Therapy | Genetics | Primary Care | Vitamin A